Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ADJU-PLATFORM

Financiado

MINIMAL SAPONIN-BASED ADJUVANT VACCINE PLATFORM

ADJU-PLATFORM seeks to leverage a breakthrough made in the ERC-2016-STG-716878 project to validate a synthetic technological platform for the efficient production of optimised saponin adjuvants and improved cost-effective vaccines... ver más

31/08/2025

ASOCIACION CENTRO...

150K€

Presupuesto del proyecto: 150K€

Líder del proyecto

ASOCIACION CENTRO DE INVESTIGACION COOPERATIV... Actividades de organizaciones profesionales asociacion

TRL 4-5 | 50K€

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-03-09

ERC-2022-POC1: ERC PROOF OF CONCEPT GRANTS1 Objective:Objectives:

I+D

Cerrada hace 3 años

0% 100% 100%

1 Participantes

ASOCIACION CENTRO DE INVESTI...

150.00K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PID2020-117911RB-I00 DISEÑO, SINTESIS, EVALUACION BIOLOGICA Y ESTUDIOS ESTRUCTURA... 145K€ Cerrado

PDC2021-121884-I00 DESARROLLO DE UNA PLATAFORMA ADYUVANTE BASADA EN SAPONINAS S... 92K€ Cerrado

ADJUV-ANT VACCINES Elucidating the Molecular Mechanisms of Synthetic Saponin Ad... 1M€ Cerrado

ADJUVACCINE Development of a marketable adjuvant candidate for vaccine a... 150K€ Cerrado

CTQ2017-87530-R DISEÑO, SINTESIS Y EVALUACION BIOLOGICA DE NUEVAS SONDAS QUI... 71K€ Cerrado

RYC-2015-17888 Synthesis and Conformational Analysis of Glycopeptides Incor... 309K€ Cerrado

Duración del proyecto: 29 meses Fecha Inicio: 2023-03-09
Fecha Fin: 2025-08-31

Líder del proyecto

ASOCIACION CENTRO DE INVESTIGACION COOPERATIV... Actividades de organizaciones profesionales asociacion

TRL 4-5 | 50K€

Presupuesto del proyecto 150K€

Descripción del proyecto ADJU-PLATFORM seeks to leverage a breakthrough made in the ERC-2016-STG-716878 project to validate a synthetic technological platform for the efficient production of optimised saponin adjuvants and improved cost-effective vaccines. We have recently developed in the laboratory a potent, safe, stable and streamlined platform based on an optimised version of the vaccine adjuvant QS-21 that has led to patent applications and raised the interest of the pharmaceutical industry. In this PoC project, we aim to exploit our synthetic saponin technology to produce scalable adjuvant and vaccine candidates that outperform existing products more cost-effectively, lowering the risk profile of the commercialisation potential, while also achieving valorisation outcomes for market entry. The goal is to demonstrate our innovative minimal adjuvant platform in relevant settings for the advancement of novel adjuvant prototypes and molecular vaccines closer to the market. The breakthrough innovation potential of ADJU-PLATFORM lies in the exploitation of this adjuvant vaccine platform for its application with additional formulation systems in a range of disease areas, expanding and improving the available vaccine solutions. The high purity and excellent chemical control over our synthetic platform compared to the heterogeneous natural product adjuvants, as well as its streamlined, modular nature and low-cost profile are distinctive attributes of our technology that will be valorised herein, making it a potentially superior alternative to existing vaccine models with less structural definition and costlier timelines. The main objectives are (1) demonstrate our synthetic technology platform for the streamlined and efficient development of scalable adjuvant and vaccine solutions and (2) implement valorisation opportunities of our platform and products by establishing an optimal IPR strategy and a go-to-market roadmap for the commercialisation.

Conecta tu I+D

Entra hoy

¿Olvide mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores